You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stage IV Adenocarcinoma of the Pancreas

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • sorafenib tosylate
  • +4 more
  • Aurora, Colorado
  • +1 more
Sep 8, 2022

Pancreatic Cancer, Pancreas Adenocarcinoma, Advanced Pancreatic Cancer Trial in United States (Pembrolizumab, paricalcitol, )

Completed
Has Results
  • Pancreatic Cancer
  • +4 more
  • Scottsdale, Arizona
  • +5 more
Dec 1, 2022

Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Buffalo (dovitinib lactate,

Completed
  • Adenocarcinoma of the Pancreas
  • +3 more
  • dovitinib lactate
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer Trial in

Suspended
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +2 more
  • gemcitabine hydrochloride
  • +4 more
  • Detroit, Michigan
  • +1 more
Feb 2, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Active, not recruiting
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +3 more
  • 6,8-bis(benzylthio)octanoic acid
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 22, 2021

Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma Trial in New

Active, not recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • +4 more
  • Falimarev
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 4, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in Bronx

Completed
Has Results
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • Bronx, New York
    Montefiore Medical Center
May 18, 2021

Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in

Active, not recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • +4 more
  • Biopsy
  • +4 more
  • Chicago, Illinois
  • +11 more
Jun 28, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
Has Results
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +3 more
  • metformin hydrochloride
  • +4 more
  • Cleveland, Ohio
  • +1 more
Aug 9, 2021

Stage IV Pancreatic Cancer Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

Terminated
Has Results
  • Stage IV Pancreatic Cancer
  • Antineoplaston therapy (Atengenal + Astugenal)
  • Houston, Texas
    Burzynski Clinic
Dec 16, 2020

Cancer Of Pancreas Trial (Analyze of GemCore status)

Not yet recruiting
  • Cancer Of Pancreas
  • Analyze of GemCore status
  • (no location specified)
Sep 19, 2023

Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical

Not yet recruiting
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • +11 more
  • Acupressure Therapy
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 12, 2023

Lung Adenocarcinoma Stage III, Lung Adenocarcinoma Stage IV, EGFR Gene Mutation Trial in Shanghai (Furmonertinib, Bevacizumab)

Recruiting
  • Lung Adenocarcinoma Stage III
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Aug 13, 2022

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +17 more
  • Biopsy
  • +3 more
  • Augusta, Georgia
  • +4 more
Jan 25, 2023

EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation Trial in Houston (other, biological, drug)

Recruiting
  • EGFR NP_005219.2:p.S492R
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Seattle (Autologous Mesothelin-specific

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Autologous Mesothelin-specific TCR-T Cells
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 31, 2023

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial

Not yet recruiting
  • Advanced Esophageal Adenocarcinoma
  • +14 more
  • (no location specified)
Jan 3, 2023

Stage IV Lung Adenocarcinoma Trial in United States (Certolizumab, cisplatin, pemetrexed)

Completed
  • Stage IV Lung Adenocarcinoma
  • Basking Ridge, New Jersey
  • +5 more
Jan 25, 2023

Metastatic Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v6 and v7, Stage IV Pancreatic Cancer AJCC v6 and v7

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Chicago, Illinois
  • +4 more
Jun 10, 2021

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage I Pancreatic Cancer Trial in United

Active, not recruiting
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • Fairfield, Connecticut
  • +8 more
Oct 31, 2022

NSCLC, Adenocarcinoma, Stage IV Trial in New York (Rigosertib, Nivolumab)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Feb 8, 2022

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

Not yet recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Nab paclitaxel
  • +5 more
  • (no location specified)
Oct 30, 2023

Lung Cancer Mutation Consortium Protocol

Active, not recruiting
  • Adenocarcinoma of Lung, Stage IV
    • Aurora, Colorado
      University of Colorado Denver Cancer Center
    Jan 30, 2023

    Lung Adenocarcinoma, Stage IV NSCLC, PD-1 Inhibitor Trial (Serplulimab and Bevacizumab injection)

    Not yet recruiting
    • Lung Adenocarcinoma
    • +3 more
    • Serplulimab and Bevacizumab injection
    • (no location specified)
    Dec 21, 2022